phenformin has been researched along with Cardiomyopathy, Hypertrophic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gray, A; Hardie, DG; Padbury, J; Phornphutkul, C; Shaw, S; Tseng, YT; Uzun, A; Xu, Y | 1 |
1 other study(ies) available for phenformin and Cardiomyopathy, Hypertrophic
Article | Year |
---|---|
A novel, de novo mutation in the
Topics: Adenosine Monophosphate; AMP-Activated Protein Kinases; Cardiomyopathy, Hypertrophic; Carrier Proteins; Case-Control Studies; DNA Mutational Analysis; Enzyme Activation; Fibroblasts; Genetic Predisposition to Disease; HEK293 Cells; Humans; Infant, Newborn; Intracellular Signaling Peptides and Proteins; Models, Molecular; Mutation, Missense; Myocytes, Cardiac; Phenformin; Phenotype; Phosphoproteins; Phosphorylation; Protein Conformation; Protein Kinase Inhibitors; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Sirolimus; Structure-Activity Relationship; TOR Serine-Threonine Kinases; Transfection | 2017 |